GIX stock forecast depends on the outlook for UpHealth, and it looks really strong. UpHealth expects its revenue to rise 67 percent year-over-year to $194 million in 2021, and between 2020 and 2022, to grow 72 percent compounded annually to $346 million. The company also foresees its adjusted EBITDA reaching $69 million by 2022, and its adjusted EBITDA margins expanding to 20 percent by 2022 from 7 percent in 2020.
UpHealth currently offers digital healthcare services, including virtual consultations, global telemedicine, and online pharmaceutical services. The company holds over 100,000 consultations per month on its digital platform, and ships more than 95 percent of prescription orders within 24 hours. Meanwhile, as Cloudbreak offers online medical interpretation services in more than 250 languages, it should help UpHealth expand internationally.
View more information: https://marketrealist.com/p/gix-stock-uphealth-merger/